LipikaGoyalMD

PubMed

• Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients.
  Hollebecque, A., Furuse, J., Oh, D., Bridgewater, J., Shimura, M., Anderson, B., Hangai, N., Wacheck, V., Meric-Bernstam, F., Goyal, L.> ;Clinical Cancer Research. 2024 Feb 8
• Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.
  Yoo, C., Lamarca, A., Choi, H., Vogel, A., Ueno, M., Märten, A., Teufel, M., Geng, L., Morizane, C., Pishvaian, M., Goyal, L.> ;Future Oncology. 2024 Jan 12
• Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
  Joy X Jarnagin, Anurag Saraf, Islam Baiev, Gary Chi, Emily E van Seventer, Amirkasra Mojtahed, Jill N Allen, Jeffrey W Clark, Lawrence Blaszkowsky, Bruce J Giantonio, ...> ;JAMA Network Open. 2023 Nov 1
• The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
  Leontios Pappas, Islam Baiev, Stephanie Reyes, Andrea Grace Bocobo, Apurva Jain, Kristen Spencer, Tri Minh Le, Osama E Rahma, Jordan Maurer, Jen Stanton, Karen Zhang, ...> ;JCO Precision Oncology. 2023 Aug 1
• 11 citations
  RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
  Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B Barry Touré, Songping Zhao, Roberto Valverde, Patrick J O'Hearn, Demetri T Moustakas, Heike Schönherr, Na...> ;Cancer Discovery. 2023 Sep 6
• 5 citations
  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer.
  Kelly, R., Bever, K., Chao, J., Ciombor, K., Eng, C., Fakih, M., Goyal, L., Hubbard, J., Iyer, R., Kemberling, H., Krishnamurthi, S., Ku, G., Mordecai, M., Morris, V.,...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 81 citations
  AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
  Amit G Singal, Josep M Llovet, Mark Yarchoan, Neil Mehta, Julie K Heimbach, Laura A Dawson, Janice H Jou, Laura M Kulik, Vatche G Agopian, Jorge A Marrero, Mishal Mend...> ;Hepatology. 2023 Dec 1
• 3 citations
  Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.
  Anuradha Budhu, Erica C Pehrsson, Aiwu He, Lipika Goyal, Robin Kate Kelley, Hien Dang, Changqing Xie, Cecilia Monge, Mayank Tandon, Lichun Ma, Mahler Revsine, Laura Ku...> ;Cell Reports. Medicine. 2023 Jun 20
• 19 citations
  Cholangiocarcinoma - novel biological insights and therapeutic strategies.
  Sumera I Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J Gores> ;Nature Reviews. Clinical Oncology. 2023 Jul 1
• 3 citations
  Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
  Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osam...> ;Journal of the National Cancer Institute. 2023 Jul 6
• 1 citations
  Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials.
  Thomas B Karasic, Jennifer R Eads, Lipika Goyal> ;JCO Precision Oncology. 2023 Apr 1
• 5 citations
  Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis.
  Felipe S Furtado, Mark Z Wu, Shadi A Esfahani, Cristina R Ferrone, Lawrence S Blaszkowsky, Jeffrey W Clark, David P Ryan, Lipika Goyal, Joseph W Franses, Jennifer Y Wo...> ;Annals of Surgery. 2023 Apr 1
• Prevalence and Clinicopathologic Characteristics of Hypercalcemia in Patients With Cholangiocarcinoma.
  Eirini Konstantinidou, Jordan R Maurer, Stephanie L Reyes, Islam Baiev, Jennifer R Stanton, Ryan D Nipp, Lipika Goyal> ;JAMA Oncology. 2023 May 1
• 3 citations
  Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
  Kimberly Perez, Anna M Chiarella, James M Cleary, Nora Horick, Colin Weekes, Thomas Abrams, Lawrence Blaszkowsky, Peter Enzinger, Marios Giannakis, Lipika Goyal, Jeffr...> ;The Oncologist. 2023 May 8
• 5 citations
  Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
  Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao, Jay Luther, Irun Bhan, Emily Bethea, Joseph W Franses, Elizabeth Paige Walsh, Leig...> ;The Oncologist. 2023 Apr 6
• 23 citations
  Immunology and immunotherapy of cholangiocarcinoma.
  Tim F Greten, Robert Schwabe, Nabeel Bardeesy, Lichun Ma, Lipika Goyal, Robin K Kelley, Xin W Wang> ;Nature Reviews. Gastroenterology & Hepatology. 2023 Jun 1
• What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published litera...
  Mairéad G McNamara, John Bridgewater, Lipika Goyal, Timothy Jacobs, Anna D Wagner, David Goldstein, Rachna Shroff, Markus Moehler, Maeve Lowery, Tanios Bekaii-Saab, Ro...> ;BMJ Open. 2022 Oct 26
• 6 citations
  Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.
  Richard S Finn, Thomas Yau, Chih-Hung Hsu, Enrico N De Toni, Lipika Goyal, Peter R Galle, ShuKui Qin, Sujata Rao, Fangfang Sun, Chunxiao Wang, Ryan C Widau, Andrew X Zhu> ;The Oncologist. 2022 Dec 9
• 6 citations
  FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures.
  Vishwajith Sridharan, Abhijit Chogule, Islam Baiev, Stephanie Reyes, Emily G Barr Fritcher, Jochen K Lennerz, William Sukov, Benjamin Kipp, David T Ting, Vikram Deshpa...> ;Clinical Cancer Research. 2022 Dec 15
• 1 citations
  in Medicine: A Role for Dance in Appreciating Nonverbal Communication in the Clinical Encounter.
  Maheetha Bharadwaj, Dipal Nagda, Lipika Goyal> ;Journal of Clinical Oncology. 2023 Jan 1
• 39 citations
  The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
  J E Berchuck, F Facchinetti, D F DiToro, I Baiev, U Majeed, S Reyes, C Chen, K Zhang, R Sharman, P L S Uson Junior, J Maurer, R T Shroff, C C Pritchard, M-J Wu, D V T ...> ;Annals of Oncology. 2022 Dec 1
• 3 citations
  An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma.
  David C Madoff, Nadine Abi-Jaoudeh, David Braxton, Lipika Goyal, Dhanpat Jain, Bruno C Odisio, Riad Salem, Mark Schattner, Rahul Sheth, Daneng Li> ;The Oncologist. 2022 Oct 1
• 4 citations
  Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
  Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Valentina Nardi, Lauren L Ritterhouse, Laura M Spring, Nicholas Jesso...> ;The Oncologist. 2022 Nov 3
• 14 citations
  Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
  Mihir Rajurkar, Aparna R Parikh, Alexander Solovyov, Eunae You, Anupriya S Kulkarni, Chong Chu, Katherine H Xu, Christopher Jaicks, Martin S Taylor, Connie Wu, Katheri...> ;Cancer Discovery. 2022 Jun 2
• 21 citations
  EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
  Qibiao Wu, Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Ramzi Adil, Joshua Merritt, Regina Egan, Meng-Ju Wu, Xunqin Yin, Cristina R Ferrone, Vikram Deshpande, ...> ;Cancer Discovery. 2022 May 2
• Join now to see all

Journal Articles

• A Phase II and Biomarker Study of Sorafenib Combined with FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)  
  Hui Zheng, Rakesh K Jain, Lipika Goyal, Andrew X Zhu, Clinical Cancer Research

Lectures

• Targeting Choangiocarcinoma: Fibroblast Growth Receptors, IDH, and Beyond 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019